Literature DB >> 3819645

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.

V Lehmann, M A Freudenberg, C Galanos.   

Abstract

The toxic properties of human recombinant tumor necrosis factor (TNF) were investigated in mice made hypersensitive to endotoxin by treatment with D-galactosamine. C3H/TifF mice treated with D-galactosamine were rendered sensitive to the lethal effects of submicrogram amounts of TNF. In the absence of D-galactosamine, TNF caused approximately 80% lethality with 500 micrograms. The duration of sensitization to TNF lasted up to 8 h after D-galactosamine administration, that towards LPS, up to 4 h. As with LPS, with TNF sensitization could be inhibited by uridine administered up to 2 h after D-galactosamine/TNF, showing that the early biochemical alterations in the liver known to be necessary for sensitization to LPS are also necessary for sensitization to TNF. In contrast to LPS, the toxicity of TNF was expressed also in D-galactosamine-treated endotoxin-resistant C3H/HeJ mice. The susceptibility of these mice to TNF was identical to that of endotoxin sensitive mice. In the absence of D-galactosamine the toxicity of TNF in C3H/HeJ mice was comparable to that obtained in C3H/TifF mice, being lethal with amounts of the order of 500 micrograms. The present results support the hypothesis that TNF is a mediator of lethal toxicity of endotoxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819645      PMCID: PMC2188282          DOI: 10.1084/jem.165.3.657

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide.

Authors:  A Coutinho; L Forni; F Melchers; T Watanabe
Journal:  Eur J Immunol       Date:  1977-05       Impact factor: 5.532

Review 2.  Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.

Authors:  K Decker; D Keppler
Journal:  Rev Physiol Biochem Pharmacol       Date:  1974       Impact factor: 5.545

3.  Genetic control of leucocyte responses to endotoxin.

Authors:  B M Sultzer
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

4.  Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal).

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-04

5.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  C57BL/10/CR mice: nonresponders to activation by the lipid a moiety of bacterial lipopolysaccharide.

Authors:  K P McAdam; J L Ryan
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

7.  Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.

Authors:  M Kawakami; P H Pekala; M D Lane; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Studies of endotoxin-induced decrease in lipoprotein lipase activity.

Authors:  M Kawakami; A Cerami
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  155 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Whole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis.

Authors:  Jamie C Merrill; Jian You; Cara Constable; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

3.  Role of NFkappaB in the mortality of sepsis.

Authors:  H Böhrer; F Qiu; T Zimmermann; Y Zhang; T Jllmer; D Männel; B W Böttiger; D M Stern; R Waldherr; H D Saeger; R Ziegler; A Bierhaus; E Martin; P P Nawroth
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 5.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation.

Authors:  Hélène Le Buanec; Laure Delavallée; Natacha Bessis; Sébastien Paturance; Bernard Bizzini; Robert Gallo; Daniel Zagury; Marie-Christophe Boissier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

7.  Abnormal immunity and gene mutation in patients with severe hepatitis-B.

Authors:  Jing-Yan Wang; Pei Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor.

Authors:  J Bartholeyns; M Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

9.  Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice.

Authors:  Matthew Giannandrea; Robert H Pierce; Ian Nicholas Crispe
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

10.  Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice.

Authors:  P Liu; H Ohnishi; H Moriwaki; Y Muto
Journal:  Gastroenterol Jpn       Date:  1990-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.